Evidence map›Paper›PMID 31227976›Full record

ArticleMolecular and cellular biochemistry2019

MiR-19b-3p attenuates IL-1β induced extracellular matrix degradation and inflammatory injury in chondrocytes by targeting GRK6.

Liang Duan, Dapeng Duan, Wenbo Wei, Zhengming Sun, Honghai Xu, Lipeng Guo, Xuanhui Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. MiR-19b-3p Attenuates Chondrocytes Injury by Inhibiting MAPK/NF-Κb Axis via Targeting SOCS1.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis.Frontiers in cell and developmental biology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liang DuanDepartment of Orthopaedics, Shaanxi Provincial People's Hospital, NO. 256 Youyi Xi Road, Xi'an, 710068, Shaanxi, China.
Dapeng DuanDepartment of Orthopaedics, Shaanxi Provincial People's Hospital, NO. 256 Youyi Xi Road, Xi'an, 710068, Shaanxi, China.
Wenbo WeiDepartment of Orthopaedics, Shaanxi Provincial People's Hospital, NO. 256 Youyi Xi Road, Xi'an, 710068, Shaanxi, China.
Zhengming SunDepartment of Orthopaedics, Shaanxi Provincial People's Hospital, NO. 256 Youyi Xi Road, Xi'an, 710068, Shaanxi, China.
Honghai XuDepartment of Orthopaedics, Shaanxi Provincial People's Hospital, NO. 256 Youyi Xi Road, Xi'an, 710068, Shaanxi, China. honghaixu@yeah.net.
Lipeng GuoDepartment of Orthopaedics, Shaanxi Provincial People's Hospital, NO. 256 Youyi Xi Road, Xi'an, 710068, Shaanxi, China.
Xuanhui WuDepartment of Orthopaedics, Shaanxi Provincial People's Hospital, NO. 256 Youyi Xi Road, Xi'an, 710068, Shaanxi, China.
Shaanxi Provincial People's Hospital · CNShanxi Medical University · CN

Funding

Shaanxi Science and Technology Co-ordination & Innovation Project 2015KTCL03-02
6 · The paper itself

Abstract

Osteoarthritis (OA) is characterized by degradation of articular cartilage. MiRNAs are involved in the regulation of chondrogenesis and OA. We aimed to investigate effects and mechanisms of miR-19b-3p in regulating chondrocytes viability, cartilage degradation and inflammatory response. Primary chondrocytes were isolated from cartilages in control subjects and patients with OA. Murine ATDC5 cells were pre-conditioned with IL-1β in vitro. Expressions and interaction of miR-19b-3p with G protein-coupled receptor kinase 6 (GRK6), and their effects on inflammation, chondrocytes viability and cartilage degradation were determined after miR-19b-3p mimic or GRK6 siRNA transfection. MiR-19b-3p was significantly decreased in OA chondrocytes and IL-1β-stimulated ATDC5 cells, in paralleled with the elevated type-II-collagen, aggrecan, MMP13 and GRK6 expression. MiR-19b-3p mimic dramatically increased the viability of chondrocytes and suppressed cell apoptosis. It also increased type-II-collagen, aggrecan expression and glycosaminoglycan (sGAG) content, and decreased the expression of MMP-1 and MMP-13 that controlled by IL-1β. Overexpression of miR-19b-3p inhibited the production of IL-6 and IL-8 in ATDC5 cells. However, the protective effects of miR-19b-3p mimic on IL-1β induced cell death; IL-8 production and sGAG decrease were greatly discounted by GRK6 lentiviral vectors. Luciferase reporter assay confirmed that GRK6 gene was a direct target ofmiR-19b-3p. GRK6 siRNA transfection antagonized the IL-1β-induced chondrocytes injury, extracellular matrix degradation and inflammatory response. MiR-19b-3p mimic and GRK6 siRNA showed comparable inhibitory effect on IL-1β-provoked NF-κB as reflected by the expression of p-p65. NF-κB translocation inhibition with PS1154 reversed the effects of IL-1β on IL-8 and sGAG. Collectively, miR-19b-3p attenuated OA by targeting GRK6-NF-κB pathway.

Indexed as

AgedCell LineChondrocytesExtracellular MatrixFemaleG-Protein-Coupled Receptor KinasesHumansInflammationInterleukin-1betaMaleMicroRNAsMiddle AgedOsteoarthritis, KneeSignal TransductionG-protein-coupled receptor kinase 6G-Protein-Coupled Receptor KinasesIL1B protein, humanInterleukin-1betaMicroRNAsMIRN19A microRNA, humanExtracellular matrix degradationGRK6InflammationmiR-19b-3pNF-κBOsteoarthritis

Identifiers

PMID31227976
OpenAlexW2950454172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.